NQTL Comparative Analysis Request: A Parity Template
How a behavioral-health provider requests a plan's nonquantitative treatment limitation analysis as the patient's representative, and what the 2026 enforcement pause does not change.
On this page: Direct answer
Direct answer
NQTL comparative analysis request: what operators need to know
How a behavioral-health provider requests a plan's nonquantitative treatment limitation analysis as the patient's representative, and what the 2026 enforcement pause does not change. The analysis belongs to the plan; the right to request it runs through the participant or beneficiary, so provider requests need a representative designation.
Parity is the argument most behavioral-health operators believe in and almost never make, because the thing that would prove it sits inside the plan. A nonquantitative treatment limitation is a rule that restricts the scope or duration of a benefit without being a dollar or visit cap — concurrent review frequency, which levels of care need authorization, network admission standards, what counts as medically necessary. The Consolidated Appropriations Act, 2021 requires plans that impose such limitations on mental health and substance use benefits to perform and document a comparative analysis showing the limitation is applied no more stringently than it is to medical and surgical benefits.
Two things make this practically useful rather than theoretical. First, a participant or beneficiary who has received an adverse determination can request that analysis, and a provider can make the request as their authorized representative. Second, the 2026 federal enforcement pause applies to provisions the 2024 final rule added — not to the underlying statutory duty to perform and produce the analysis. This guide gives you the letter and is explicit about which parts of the ground are firm.
Key takeaways
The short version
- The analysis belongs to the plan; the right to request it runs through the participant or beneficiary, so provider requests need a representative designation.
- The statutory comparative-analysis duty has applied since February 2021 and is not suspended by the 2026 enforcement pause.
- What the Departments paused is enforcement of provisions the September 2024 final rule added. Read the DOL statement rather than a summary of it.
- Ask about one specific limitation tied to one specific denial. A request for everything invites a refusal; a request about concurrent review frequency for residential care is answerable.
- In-network providers can often obtain medical necessity criteria directly under contract — a narrower right, but much faster.
- A parity issue is usually a contracting and regulator conversation, not an appeals-desk one. Build the pattern, then escalate it.
Take the template with you
Free to copy · no email required
NQTL comparative analysis request
A scoped request naming one limitation, the medical/surgical analogue, and the six content elements, with the authorized-representative block that gives it standing.
Saves as nqtl-comparative-analysis-request.txt
Parity pattern log
One row per denial, recording the limitation encountered and the medical/surgical analogue, so a pattern across a plan becomes visible without storing clinical detail.
case_ref,payer,plan_or_group,funding,line_of_business,level_of_care,limitation_encountered,review_cadence_days,criteria_set_named,medical_surgical_analogue,analogue_cadence_days_if_known,determination_date,outcome,overturned_on_appeal,analysis_requested_date,analysis_response,escalated_to,notes PAR-0001,[payer],[group number],self-funded / fully insured,ERISA group / Marketplace / Medicaid MC,Residential SUD,concurrent review every 3 days,3,"[criteria, edition]",skilled nursing concurrent review,7,2026-10-06,downgraded,pending,2026-10-09,,plan sponsor / state DOI / contracting,
Saves as parity-pattern-log.csv
1. What counts as a nonquantitative treatment limitation
A quantitative limit is countable: twenty visits, a $40 copay, a thirty-day cap. A nonquantitative treatment limitation shapes access without a number, and it is where behavioral-health disparity actually lives. If a plan reviews residential behavioral-health stays every three days but reviews skilled nursing stays weekly, no visit cap has been breached and the practical effect is still a materially harder benefit to use.
The analysis is the plan's own documentation that the limitation, as written and as applied, is comparable to and no more stringently applied than the corresponding limitation on medical and surgical benefits. The comparison is to the medical and surgical side, which is why the most effective requests name the medical or surgical analogue you want the comparison against.
| Limitation you encounter | Why it is an NQTL | The medical/surgical analogue to name |
|---|---|---|
| Concurrent review every 3 days for residential care | Frequency of review restricts benefit duration without a cap | Concurrent review cadence for skilled nursing or inpatient rehabilitation |
| Prior authorization required for all levels of behavioral-health care | Authorization requirement is a scope limitation | Which medical and surgical services at comparable intensity require authorization |
| Proprietary level-of-care criteria not used on the medical side | Standard applied is a limitation on medical necessity | The criteria source used for analogous medical and surgical determinations |
| Network admission standards or reimbursement methodology | Restricts practical access to in-network care | Admission standards and methodology for medical and surgical specialties |
| Step-therapy style requirements for level of care | Requires failure at a lower level first | Whether analogous medical services require a failed lower-intensity trial |
| Written treatment plan submission requirements | Documentation burden as a condition of benefit | Documentation required for analogous medical and surgical services |
2. Who may request it, and how a provider gets standing
Three categories of requester matter. Federal regulators — the Departments of Labor, Health and Human Services, and the Treasury — can demand the analysis. Applicable state authorities can request it for the plans they regulate. And a participant or beneficiary who has received an adverse benefit determination relating to mental health or substance use benefits can request it, including through a person acting as their authorized representative.
A provider is in that third category only. You are not an independent requester, and a letter that implies otherwise is easy to refuse. The workable path is the same one that makes claim file requests work: a signed designation collected at admission, naming the plan and the episode, with scope that covers claims, appeals, and document requests.
- Collect the authorized-representative designation at admission for every patient with employer-sponsored coverage.
- Tie the request to a specific adverse determination; that is the trigger the right attaches to.
- Use the plan's own designation form where it has one, to remove a procedural objection.
- If you are in-network, ask your contract manager whether criteria are available directly — faster, narrower, and often sufficient.
- For self-funded employer plans, the plan sponsor is a real audience: the employer is paying for a benefit its employees cannot use.
- Where state-regulated insurance is involved, the state insurance regulator can request the analysis and often responds to a documented pattern.
3. What the 2026 enforcement pause does and does not do
In 2026 the Departments stated they would not enforce certain provisions that the September 2024 final rule added, pending further rulemaking. This is widely described as parity being suspended. That is not what it says, and the distinction is the whole basis for still sending the letter.
What is paused is federal enforcement of specific additions made by the 2024 rule. The statutory requirement to perform and document a comparative analysis, in place since February 2021, is unaffected. State authority over state-regulated insurance is unaffected. Plan-document and benefit obligations are unaffected. And participants' appeal rights, including the document entitlements under the ERISA claims procedure regulation, are unaffected.
| Element | Status to rely on | Practical effect |
|---|---|---|
| Statutory duty to perform and document a comparative analysis | In force since February 2021 | The analysis should exist; asking whether it does is a fair question |
| Duty to produce it to federal or state regulators on request | In force | A regulator complaint has a concrete thing to ask for |
| Provisions added by the 2024 final rule | Federal enforcement paused per the DOL statement | Do not build an argument that depends only on these |
| State insurance regulation of state-regulated plans | Unaffected by the federal pause | Often the most responsive channel for fully insured business |
| ERISA claims procedure document rights | Unaffected | The claim file route remains available regardless |
| Future rulemaking | The Departments have indicated an intent to propose a new rule | Treat the current position as a moving target and re-check before relying on it |
4. Writing a request that can be answered
- 01
Anchor it to one adverse determination
Name the member, the claim, the dates, the level of care, and the denial. The right attaches to the determination, so the determination has to be in the letter.
- 02
Name one limitation precisely
Not "your behavioral health rules" but "the frequency of concurrent review applied to residential substance use treatment under this plan".
- 03
Name the medical/surgical comparison you want
State the analogue explicitly. This is what turns a vague request into a comparison the plan has to address or explain away.
- 04
Ask for the six content elements
The factors used, the sources for those factors, the standards applied, how the limitation is applied in writing, how it is applied in operation, and the plan's conclusion with its reasoning.
- 05
Ask for the in-operation data
Written comparability is the easy half. Ask how the limitation operates in practice — denial and overturn rates on each side of the comparison.
- 06
Keep the claim file request alongside it
The claim file is faster and more certain. Parity is the structural argument; the file is the case-level one. Send both.
5. Where a parity finding actually goes
An appeals coordinator cannot fix a plan's NQTL. Treating parity as an appeals tactic produces frustration; treating it as evidence for three other conversations produces movement.
- Plan sponsor, for self-funded employer coverage: the employer chose this administrator and can ask it questions you cannot.
- State insurance regulator, for fully insured and state-regulated business: a documented pattern with dates and verbatim notice text is actionable.
- Your contracting lead: review cadence and criteria source are negotiable terms, and a documented disparity is leverage at renewal.
- Federal regulators, where the conduct is systemic: the Departments can request the analysis directly.
- Your own appeal, as a supporting argument rather than the lead one, where the facts support it.
- Trade associations, which can aggregate what no single practice can: your twelve cases plus forty others is a different artifact.
Common questions
Answers before you build.
Can we request the comparative analysis directly as a provider?+
Not in your own right. The requester categories are federal regulators, applicable state authorities, and participants or beneficiaries who have received an adverse determination — the last of which includes a provider acting as an authorized representative. Attach a signed designation, or the request is straightforward to refuse.
Is parity enforcement suspended in 2026?+
No, though it is narrower than it was. The Departments stated they will not enforce certain provisions the 2024 final rule added, pending further rulemaking. The statutory duty to perform and document the analysis, state authority over state-regulated insurance, and participants' appeal and document rights all remain. Confirm the current position on the day you rely on it.
What is the difference between asking for criteria and asking for the analysis?+
Criteria tell you the standard the plan applied to your patient. The comparative analysis tells you whether that standard, and how it is operated, is more stringent than the medical and surgical equivalent. The first helps one appeal; the second is structural. In-network providers can often get criteria directly under contract, which makes it the faster first ask.
What should we do if the plan says the analysis is confidential or proprietary?+
Record the response verbatim and keep it. Confidentiality concerns can be addressed through redaction or protective terms rather than wholesale refusal, and a written refusal is itself useful material for the plan sponsor or the state regulator.
How long does this take to be worth anything?+
Longer than an appeal and shorter than a contract cycle. Think in quarters: build the log, send requests on the cases that fit, and bring the aggregate to renewal or to a regulator. If you need something to change this week, the claim file and the clinical appeal are the tools.
Practical closeout
Use this operator checklist.
- The analysis belongs to the plan; the right to request it runs through the participant or beneficiary, so provider requests need a representative designation.
- The statutory comparative-analysis duty has applied since February 2021 and is not suspended by the 2026 enforcement pause.
- What the Departments paused is enforcement of provisions the September 2024 final rule added. Read the DOL statement rather than a summary of it.
- Ask about one specific limitation tied to one specific denial. A request for everything invites a refusal; a request about concurrent review frequency for residential care is answerable.
- In-network providers can often obtain medical necessity criteria directly under contract — a narrower right, but much faster.
- A parity issue is usually a contracting and regulator conversation, not an appeals-desk one. Build the pattern, then escalate it.
Continue through the cluster
Verified customer case studies are added only with customer permission and supporting evidence; none is implied by these operational examples.
Sources & methodology
Trace the operational claims.
Marsa Health Editorial reviewed the primary and research sources below on October 18, 2026. We translate them into workflow controls, distinguish proposals from final rules, and flag where plan, program, state, contract, or clinical requirements vary.
- 01Requirements Related to the Mental Health Parity and Addiction Equity Act Federal RegisterThe September 2024 final rule, including who may request a comparative analysis and what a sufficient analysis contains.Accessed or rechecked October 18, 2026
- 02Statement regarding enforcement of the 2024 MHPAEA final rule U.S. Department of Labor, Employee Benefits Security AdministrationThe Departments' non-enforcement position on provisions added by the 2024 final rule. The underlying statutory comparative-analysis duty is unaffected.Accessed or rechecked October 18, 2026
- 0329 CFR 2590.712: Parity in mental health and substance use disorder benefits Electronic Code of Federal RegulationsThe Labor Department's MHPAEA rule, including the nonquantitative treatment limitation standard and the documents a plan must be able to produce about it.Accessed or rechecked October 18, 2026
- 0429 CFR 2560.503-1: Claims procedure Electronic Code of Federal RegulationsParagraph (h)(3)(i) gives group health claimants 180 days to appeal; (h)(2)(iii) requires reasonable access to and free copies of all documents relevant to the claim; (m)(8) defines what counts as relevant.Accessed or rechecked October 18, 2026
- 05Appealing health plan decisions Centers for Medicare & Medicaid ServicesCMS guidance on internal claims and appeals rights, notice contents, and the relationship between internal appeals and external review.Accessed or rechecked October 18, 2026
- 06CMS Interoperability and Prior Authorization Final Rule CMS-0057-F Centers for Medicare & Medicaid ServicesCurrent implementation dates, decision timeframes, denial-reason requirements, metrics, and API provisions for impacted payers.Accessed or rechecked October 18, 2026
- 07Electronic Prior Authorization Centers for Medicare & Medicaid ServicesCurrent CMS provider-readiness guidance for 2027 electronic prior authorization, EHR questions, FHIR testing, and workflow preparation.Accessed or rechecked October 18, 2026
- 08Minimum Necessary Requirement U.S. Department of Health and Human ServicesHIPAA guidance on limiting uses, disclosures, and requests for protected health information when the standard applies.Accessed or rechecked October 18, 2026
Organizational author. Editorial review covers source accuracy, search intent, workflow boundaries, and human-oversight requirements. This material is educational and does not provide clinical, legal, coding, or coverage advice.
No named clinical or legal expert reviewer is attributed to this version. Marsa Health does not invent reviewer credentials.
Read our editorial methodRevision history
What changed and when
October 18, 2026
Initial publication, source review, and operational editing.